Marketing Authorization application of Xervyteg® (MaaT013) in acute graft-versus-host-disease submitted to the European Medicines Agency (EMA) in June 2025 MAA could be expected in H2 2026 allowing, if approved, for commercialization of Xervyteg® in Europe As part of a strategic focus on Xervyteg®’s registration activities in Europe, the Phase 3 dedicated trial launch in the … [Read more…]
NEW YORK–(BUSINESS WIRE)–Surgimate, a leading provider of surgical coordination and scheduling software in the U.S., today announced the appointment of Jessica Cook to the newly created position of Chief Revenue Officer. As CRO, Cook will oversee all sales and marketing efforts across Surgimate’s business lines, including surgical scheduling, medical device coordination and patient access. She … [Read more…]
The new suite of products unlocks greater access to Hi-C metagenomic research, accelerating discovery from complex microbial communities in human and environmental research applications SEATTLE–(BUSINESS WIRE)–Phase Genomics, Inc., a leader in genomic technology development, today announced the launch of its new ProxiMeta Starter and Elite Bundles, comprehensive product offerings that make genome- and mobilome-resolved metagenomics … [Read more…]
PARMA, Italy–(BUSINESS WIRE)–#ChiesiGlobalRareDiseases–Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative solutions for people living with rare diseases, today announced the recipients of its “Find For Rare” research grant program. The independently assessed, expert-led research grant initiative aims to improve patient care and management by recognising innovative research in … [Read more…]
New office located in the heart of Uxbridge underscores Celltrion’s long-term business commitment in the UK LONDON–(BUSINESS WIRE)–Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK, reinforcing the company’s dedication to long-term growth and partnership in the UK market. The opening ceremony was attended by Hyoung-Ki Kim, CEO … [Read more…]
Gilead prices potential ‘game changer for HIV prevention’ at an eyepopping $28K per year LOS ANGELES–(BUSINESS WIRE)–The U.S. Food and Drug Administration approved use of Gilead’s HIV treatment medication, lenacapavir, for use to prevent HIV infection earlier today, an action which was followed by news that Gilead intends to price the HIV prevention medication at … [Read more…]
– Monjuvi® (tafasitamab-cxix) in combination with rituximab and lenalidomide is the first FDA-approved CD19- and CD20-targeted immunotherapy combination for adult patients with follicular lymphoma (FL) – Patients with relapsed or refractory FL achieved significantly improved progression-free survival with Monjuvi in combination with rituximab and lenalidomide in the Phase 3 registration trial – This milestone represents … [Read more…]
SAN FRANCISCO–(BUSINESS WIRE)–Abridge, a leading generative AI platform for clinical conversations, is expanding its capabilities to support inpatient care settings and queue up outpatient orders—extending the value of clinical conversations through additional integrated workflows as part of Workshop, a program through which Epic and Abridge have worked together to develop new, innovative healthcare technologies that … [Read more…]
Company welcomes Chiquita Brooks-LaSure and Kate O’Neill as keynote speakers LOS ANGELES–(BUSINESS WIRE)–mPulse, a leading provider of Health Experience and Insights (HXI) technology, today announced details for Activate2025, the company’s industry conference for healthcare executives to learn, network, and celebrate innovative health engagement. This year’s event will convene healthcare and technology thought leaders in Austin, … [Read more…]
Biotech social venture honored for its groundbreaking AI platform transforming antibiotic discovery CAMBRIDGE, Mass.–(BUSINESS WIRE)–Phare Bio, a biotech social venture harnessing generative AI to develop novel antibiotics, has been named the winner of the “Best Of – Most Innovative Technology or Service” category in Newsweek’s 2025 AI Impact Awards. The honor recognizes Phare Bio’s pioneering … [Read more…]
